Loading
HKSEHealthcareBiotechnology
Latest quote
HK$1.27
HK$0.00 · 0.00%
BrainAurora Medical Technology Limited provides system integral software solutions for hospitals and research projects in Mainland China. The company develops medical-grade digital therapy (DTx) products for cognitive impairment. It offers the evaluation and intervention of cognitive impairments to treat vascular diseases, neurodegenerative diseases, psychological disorders, and child development deficiencies. The company develops the Brain Function Information Management Platform software system, an evidence-based, medical-grade DTx product; Basic Cognitive Testing Software, an assessment of patients for basic cognitive capacity; Cognitive Ability Supplemental screening and assessment software, a solution designed to facilitate healthcare professionals assessment of patients; and Dyslexia Supplemental Screening and Assessment Software, a solution designed to facilitate the assessment of risk of developmental dyslexia in children. It also develops covid-19 induced cognitive impairment assessment and recovery training software; ADHD assessment and treatment software; quantitative cognitive assessment software for depression; depression treatment software; and cognitive impairment assessment software and cognitive impairment treatment software solutions. In addition, the company provides marketing services. BrainAurora Medical Technology Limited was founded in 2012 and is headquartered in Shaoxing, China.
Latest quote
HK$1.27
HK$0.00 · 0.00%
Regular session · HKT · Market data may be delayed.
BrainAurora Medical Technology Limited provides system integral software solutions for hospitals and research projects in Mainland China. The company develops medical-grade digital therapy (DTx) products for cognitive impairment. It offers the evaluation and intervention of cognitive impairments to treat vascular diseases, neurodegenerative diseases, psychological disorders, and child development deficiencies. The company develops the Brain Function Information Management Platform software system, an evidence-based, medical-grade DTx product; Basic Cognitive Testing Software, an assessment of patients for basic cognitive capacity; Cognitive Ability Supplemental screening and assessment software, a solution designed to facilitate healthcare professionals assessment of patients; and Dyslexia Supplemental Screening and Assessment Software, a solution designed to facilitate the assessment of risk of developmental dyslexia in children. It also develops covid-19 induced cognitive impairment assessment and recovery training software; ADHD assessment and treatment software; quantitative cognitive assessment software for depression; depression treatment software; and cognitive impairment assessment software and cognitive impairment treatment software solutions. In addition, the company provides marketing services. BrainAurora Medical Technology Limited was founded in 2012 and is headquartered in Shaoxing, China.
Day range
Current HK$1.27
52-week range
Current HK$1.27
Regular session · HKT · Market data may be delayed.
BrainAurora Medical Technology Limited provides system integral software solutions for hospitals and research projects in Mainland China. The company develops medical-grade digital therapy (DTx) products for cognitive impairment. It offers the evaluation and intervention of cognitive impairments to treat vascular diseases, neurodegenerative diseases, psychological disorders, and child development deficiencies. The company develops the Brain Function Information Management Platform software system, an evidence-based, medical-grade DTx product; Basic Cognitive Testing Software, an assessment of patients for basic cognitive capacity; Cognitive Ability Supplemental screening and assessment software, a solution designed to facilitate healthcare professionals assessment of patients; and Dyslexia Supplemental Screening and Assessment Software, a solution designed to facilitate the assessment of risk of developmental dyslexia in children. It also develops covid-19 induced cognitive impairment assessment and recovery training software; ADHD assessment and treatment software; quantitative cognitive assessment software for depression; depression treatment software; and cognitive impairment assessment software and cognitive impairment treatment software solutions. In addition, the company provides marketing services. BrainAurora Medical Technology Limited was founded in 2012 and is headquartered in Shaoxing, China.
Day range
Current HK$1.27
52-week range
Current HK$1.27
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 220.05M CNY | 122.31M CNY | 67.2M CNY | 11.29M CNY | 2.3M CNY |
| Cost of goods sold | 130.6M CNY | 68.3M CNY | 35.14M CNY | 7.99M CNY | 995K CNY |
| Gross profit | 89.45M CNY | 54.01M CNY | 32.06M CNY | 3.3M CNY | 1.3M CNY |
| Research and development | 165.9M CNY | 119.42M CNY | 90.73M CNY | 67.63M CNY | 32.76M CNY |
| Selling, general, and administrative | 175.58M CNY | 107.94M CNY | 88.12M CNY | 15.83M CNY | 11.45M CNY |
| Operating expenses | 380.41M CNY | 226.28M CNY | 178M CNY | 107.61M CNY | 70.45M CNY |
| Interest income | 13.65M CNY | 627K CNY | 2.08M CNY | 3.9M CNY | 1.33M CNY |
| Interest expense | 23.99M CNY | 22.03M CNY | 20.22M CNY | 19.22M CNY | 6.39M CNY |
| Depreciation and amortization | 14.27M CNY | 17.55M CNY | 21.27M CNY | 12.43M CNY | 1.63M CNY |
| Operating income | −290.95M CNY | −172.27M CNY | −145.93M CNY | −104.32M CNY | −69.15M CNY |
| Net income | −314.86M CNY | −198.28M CNY | −359.08M CNY | −502.45M CNY | −697.84M CNY |
Company facts updated Sep 10, 2026.
Recent quarterly results
Recent quarterly results
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
